This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Gris-PEG

Valeant Pharmaceuticals International, Inc.

Drug Names(s): griseofulvin ultramicrosize

Description: Gris-PEG is an oral antifungal agent.

Deal Structure: Valeant and Pedinol
In April 2012, Valeant acquired Pedinol Pharmacal for less than 1.5 times sales. Revenue for 2011 was approximately $18 million and the transaction was expected to be immediately accretive.


Gris-PEG News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug